Filter
5083
Filtered Results: 5083
Text search:
drug
quality
Featured
Recommendations
460
New Publications
1433
Language
Document type
No document type
3172
Studies & Reports
735
Guidelines
649
Manuals
212
Strategic & Response Plan
146
Fact sheets
66
Training Material
55
Situation Updates
17
Infographics
14
Resource Platforms
9
Brochures
5
Online Courses
2
App
1
Countries / Regions
India
315
Kenya
164
Global
154
South Africa
125
Ethiopia
123
Uganda
120
Western and Central Europe
105
Nigeria
103
Nepal
102
Tanzania
89
Malawi
87
Sierra Leone
85
Liberia
83
Zambia
80
Ghana
73
Africa
69
Bangladesh
69
Myanmar / Burma
68
Latin America and the Carribbean
62
Rwanda
61
Namibia
49
Eastern Europe
47
Ukraine
46
Philippines
41
Cambodia
40
Zimbabwe
39
Lesotho
33
Asia
33
South–East Asia Region
32
Botswana
29
Senegal
27
Congo, Democratic Republic of
27
Russia
25
Indonesia
25
Burkina Faso
21
Syria
20
Mozambique
20
Eswatini/ Swaziland
19
Brazil
18
Haiti
16
East and Southern Africa
15
Cameroon
14
USA
14
West and Central Africa
13
Eastern Europe and Central Asia
13
Tajikistan
11
Germany
11
Middle East and North Africa
11
Georgia
11
South Sudan
11
Colombia
10
Albania
10
Pakistan
10
Thailand
9
Benin
9
Vietnam
9
Afghanistan
8
Venezuela
8
Sudan
8
Laos
7
Guinea
7
North Macedonia
6
Western Pacific Region
6
Moldova
6
China
5
Chile
5
Armenia
5
Paraguay
5
Lebanon
5
Iraq
5
Madagascar
5
Peru
4
Jordan
4
Jamaica
4
United Kingdom
4
Argentina
4
Sri Lanka
4
Mexico
3
El Salvador
3
Turkey
3
Kyrgyzstan
3
Morocco
3
North America
3
Southern Africa
3
Bolivia
3
Bhutan
3
Timor Leste/ East Timor
2
Kazakhstan
2
Iran
2
Fiji
2
Estonia
2
Mongolia
2
Hungary
2
Saudi Arabia
2
Gabon
2
Belgium
2
France
2
Tunisia
2
Portugal
2
Belarus
2
Papua New Guinea
2
Yemen
2
Palestine
2
Central African Republic
2
Poland
2
Mali
2
Libya
2
Somalia
2
Switzerland
1
Serbia
1
Australia
1
Gambia
1
Canada
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Romania
1
Greece
1
Honduras
1
Angola
1
Authors & Publishers
Publication Years
Category
Countries
2070
Clinical Guidelines
461
Public Health
258
Women & Child Health
196
Key Resources
101
Pharmacy & Technologies
69
Capacity Building
68
Annual Report MEDBOX
1
Toolboxes
HIV
593
Mental Health
482
TB
468
AMR
275
COVID-19
184
Pharmacy
183
NTDs
136
NCDs
112
Caregiver
106
Rapid Response
75
Planetary Health
66
Refugee
62
Ebola
61
Disability
58
Conflict
53
Global Health Education
51
Health Financing Toolbox
27
Natural Hazards
21
Polio
18
Cholera
14
Social Ethics
14
Zika
11
Specific Hazards
10
Health Financing
1
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
To assess national-level responses to NCDs, WHO has implemented NCD country capacity surveys periodically since 2001. This report is the latest in that series. Since the first survey round, the NCD Country Capacity Survey (NCD CCS) has been conducted a further seven times, most recently in 2021. In ...
This report presents findings from research conducted by Economist Impact to assess the health, demographic, social and economic impacts associated with different scenarios for financing the HIV epidemic across 13 selected countries in Sub-Saharan Africa. The sponsorship of UNAIDS towards this repor...
The High-Level Panel on International Financial Accountability, Transparency and Integrity for Achieving the 2030 Agenda (FACTI Panel) was convened by the 74th President of United Nations General Assembly and the 75th President of the Economic and Social Council on 2 March 2020. The objective of the...
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
This report highlights the work of the World Health Organization (WHO) in Zimbabwe towards contributing to the triple billion targets in the context of the Sustainable Development Goals (SDGs
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one of the most serious public health burdens among the most deprived communities, have only recently drawn the atte...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
Strengthening resource tracking and monitorig health expanditure
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...
